Severe digital ischaemia treated with phosphodiesterase inhibitors.
作者信息
Kumana C R, Cheung G T Y, Lau C S
出版信息
Ann Rheum Dis. 2004 Nov;63(11):1522-4. doi: 10.1136/ard.2003.015677.
Abstract
摘要
相似文献
1
Severe digital ischaemia treated with phosphodiesterase inhibitors.
Ann Rheum Dis. 2004 Nov;63(11):1522-4. doi: 10.1136/ard.2003.015677.
2
Sildenafil in HIV-related pulmonary hypertension.
AIDS. 2001 Sep 7;15(13):1747-8. doi: 10.1097/00002030-200109070-00026.
3
Sildenafil for pulmonary hypertension in pregnancy?
Anesthesiology. 2006 Feb;104(2):382; author reply 383. doi: 10.1097/00000542-200602000-00037.
4
Sildenafil citrate therapy for pulmonary arterial hypertension.
N Engl J Med. 2006 Mar 9;354(10):1091-3; author reply 1091-3.
5
Sildenafil can increase the response to inhaled nitric oxide.
Anesthesiology. 2000 Jun;92(6):1827-9. doi: 10.1097/00000542-200006000-00044.
6
[Long-term effects of sildenafil in a patient with scleroderma-associated pulmonary hypertension and Raynaud's syndrome].
Dtsch Med Wochenschr. 2004 Aug 13;129(33):1736-40. doi: 10.1055/s-2004-829025.
7
[Sildenafil in the treatment of digital ulcers in patients with systemic sclerosis].
Actas Dermosifiliogr. 2009 Nov;100(9):830-2.
8
Therapy of pulmonary hypertension: targeting pathogenic mechanisms with selective treatment delivery.
Crit Care Med. 2001 May;29(5):1086-7. doi: 10.1097/00003246-200105000-00047.
9
Sustained long-term benefit of sildenafil in primary pulmonary hypertension.
Acta Cardiol. 2007 Feb;62(1):47-9. doi: 10.2143/AC.62.1.2019370.
10
Sildenafil for "blue babies". Such unlicensed drug use might be justified as last resort.
BMJ. 2002 Nov 16;325(7373):1174. doi: 10.1136/bmj.325.7373.1174/a.
引用本文的文献
1
Suspected symmetrical peripheral gangrene in a cat.
JFMS Open Rep. 2019 Jun 18;5(1):2055116919855539. doi: 10.1177/2055116919855539. eCollection 2019 Jan-Jun.
2
Symmetrical peripheral gangrene-a case report and brief review.
Indian J Surg. 2013 Jun;75(Suppl 1):163-5. doi: 10.1007/s12262-012-0576-7. Epub 2012 Jun 16.
3
Raynaud's phenomenon and vitamin D.
Rheumatol Int. 2013 Mar;33(3):751-5. doi: 10.1007/s00296-012-2445-x. Epub 2012 May 12.
4
[Critical limb ischemia in systemic sclerosis].
Z Rheumatol. 2012 Jun;71(4):261-9. doi: 10.1007/s00393-011-0914-3.
5
Phosphodiesterase inhibitors in vascular ischemia: A case report and review of their use in ischemic conditions.
Can J Plast Surg. 2010 Spring;18(1):e5-9.
6
Oral sildenafil increases skin hyperaemia induced by iontophoresis of sodium nitroprusside in healthy volunteers.
Br J Pharmacol. 2010 Jul;160(5):1128-34. doi: 10.1111/j.1476-5381.2010.00778.x.
7
Advances in the treatment of Raynaud's phenomenon.
Vasc Health Risk Manag. 2010 Mar 24;6:167-77. doi: 10.2147/vhrm.s4551.
8
Recent achievements in the management of Raynaud's phenomenon.
Vasc Health Risk Manag. 2010 Apr 15;6:207-14. doi: 10.2147/vhrm.s5255.
9
New lines in therapy of Raynaud's phenomenon.
Rheumatol Int. 2009 Feb;29(4):355-63. doi: 10.1007/s00296-008-0792-4. Epub 2008 Nov 27.
10
[Primary and secondary Raynaud's phenomenon].
Z Rheumatol. 2008 May;67(3):211-7; quiz 218-9. doi: 10.1007/s00393-008-0282-9.
Zotero 插件